Lipofibrate

Lipofibrate may be available in the countries listed below.

Ingredient matches for Lipofibrate

Clinofibrate

Clinofibrate is reported as an ingredient of Lipofibrate in the following countries:

• Japan

International Drug Name Search

Doxazosina Ratiopharm

Doxazosina Ratiopharm may be available in the countries listed below.

Ingredient matches for Doxazosina Ratiopharm

Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosina Ratiopharm in the following countries:

• Spain

International Drug Name Search

Nicomol

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0027959-26-8

Chemical Formula

C34-H32-N4-O9

Molecular Weight

640

Therapeutic Category

Antilipemic agent

Chemical Name

3-Pyridinecarboxylic acid, (2-hydroxy-1,3-cyclohexanediylidene)tetrakis(methylene) ester

Foreign Names

• Nicomolum (Latin)
• Nicomol (German)
• Nicomol (French)
• Nicomol (Spanish)

Generic Names

• Nicomol (OS: JAN)
• K 31 (IS)
• Nicomol (PH: JP XIV)

Brand Names

• Atomirate
  Isei, Japan



• Cholexamin
  Kyorin, Japan; Shinlin Sinseng, Taiwan



• Kotomol
  Kotobuki Seiyaku, Japan



• Nicomolin
  Toyo Capseru, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Octim

Octim may be available in the countries listed below.

UK matches:

• Octim Injection (SPC)
• Octim Nasal Spray (SPC)

Ingredient matches for Octim

Desmopressin

Desmopressin acetate (a derivative of Desmopressin) is reported as an ingredient of Octim in the following countries:

• France


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Stela

Stela may be available in the countries listed below.

Ingredient matches for Stela

Trifluoperazine

Trifluoperazine hydrochloride (a derivative of Trifluoperazine) is reported as an ingredient of Stela in the following countries:

• Bangladesh

International Drug Name Search

Purgoxin

Purgoxin may be available in the countries listed below.

Ingredient matches for Purgoxin

Digoxin

Digoxin is reported as an ingredient of Purgoxin in the following countries:

• South Africa

International Drug Name Search

Betamethasone

In some countries, this medicine may only be approved for veterinary use.

In the US, Betamethasone (betamethasone systemic) is a member of the drug class glucocorticoids and is used to treat Bursitis, Dermatological Disorders, Gouty Arthritis, Inflammatory Conditions and Osteoarthritis.

US matches:

• Betamethasone


• Betamethasone Dipropionate (Augmented) Cream


• Betamethasone Dipropionate (Augmented) Lotion


• Betamethasone Dipropionate Cream


• Betamethasone Dipropionate Gel


• Betamethasone Dipropionate Lotion


• Betamethasone Solution


• Betamethasone Valerate Cream


• Betamethasone Valerate Foam


• Betamethasone Valerate Lotion


• Betamethasone/Calcipotriene Ointment


• Betamethasone/Calcipotriene Suspension


• Betamethasone and calcipotriene topical


• Betamethasone and clotrimazole topical


• Betamethasone topical


• Betamethasone Topical application


• Betamethasone and calcipotriene Topical application


• Betamethasone dipropionate Topical application


• Betamethasone valerate Topical application


• Betamethasone Acetate


• Betamethasone Dipropionate topical


• Betamethasone Valerate topical


• Betamethasone Cream


• Betamethasone Cream Augmented


• Betamethasone Dipropionate


• Betamethasone Gel


• Betamethasone Lotion Augmented


• Betamethasone Ointment


• Betamethasone Ointment Augmented


• Betamethasone Sodium Phosphate and Betamethasone Acetate


• Betamethasone Valerate


• Betamethasone/Clotrimazole

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A07EA04,C05AA05,D07AC01,D07XC01,H02AB01,R01AD06,R03BA04,S01BA06,S01CB04,S02BA07,S03BA03

CAS registry number (Chemical Abstracts Service)

0000378-44-9

Chemical Formula

C22-H29-F-O5

Molecular Weight

392

Therapeutic Category

Adrenal cortex hormone, glucocorticoid

Chemical Name

Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11ß,16ß)-

Foreign Names

• Betamethasonum (Latin)
• Betamethason (German)
• Bétaméthasone (French)
• Betametasona (Spanish)

Generic Names

• Betametasone (OS: DCIT)
• Betamethasone (OS: USAN, BAN)
• Bétaméthasone (OS: DCF)
• Flubenisolone (IS: USA hum. AHFS)
• Sch 4831 (IS)
• Visubeta (IS)
• Betamethason (PH: Ph. Eur. 6)
• Betamethasone (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
• Bétaméthasone (PH: Ph. Eur. 6)
• Betamethasonum (PH: Ph. Int. 4, Ph. Eur. 6)
• Betamethasone Dipropionate (OS: BANM, USAN)
• Sch 11460 (IS: Schering)
• Betamethasondipropionat (PH: Ph. Eur. 6)
• Bétaméthasone (dipropionate de) (PH: Ph. Eur. 6)
• Betamethasone Dipropionate (PH: BP 2010, JP XV, USP 32, Ph. Eur. 6)
• Betamethasoni dipropionas (PH: Ph. Eur. 6)
• Betamethasone Benzoate (OS: USAN)
• W 5975 (IS)
• Betamethasone Benzoate (PH: USP 32)
• Betamethasone Valerate (OS: BANM, USAN)
• B 17-V (IS)
• Betamethason-17-pentanoat (IS)
• Betamethasoni valeras (IS)
• Bétaméthasone (valérate de) (PH: Ph. Eur. 6)
• Betamethasone Valerate (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
• Betamethasoni valeras (PH: Ph. Int. 4, Ph. Eur. 6)
• Betamethasonvalerat (PH: Ph. Eur. 6)
• Betamethasone Sodium Phosphate (OS: BANM, BAN, JAN)
• Betamethasondihydrogenphosphat-Dinatrium (PH: Ph. Eur. 6)
• Bétaméthasone (phosphate sodique de) (PH: Ph. Eur. 6)
• Betamethasone Sodium Phosphate (PH: BP 2010, JP XV, USP 32, Ph. Eur. 6)
• Betamethasoni natrii phosphas (PH: Ph. Eur. 6)
• Betamethasone Acetate (OS: BANM, BAN, JAN)
• Betamethasoni acetas (IS)
• Betamethasonacetat (PH: Ph. Eur. 6)
• Bétaméthasone (acétate de) (PH: Ph. Eur. 6)
• Betamethasone Acetate (PH: BP 2010, USP 32, Ph. Eur. 6)
• Betamethasoni acetas (PH: Ph. Eur. 6)
• Betamethasone 21-acetate 17-valerate (IS)

Brand Names

• Behealth (Betamethasone and Dexchlorpheniramine)
  Nichi-Iko PharmaceuticalJMA, Japan



• Belogent (Betamethasone and Gentamicine)
  Belupo, Slovenia



• Belosalic (Betamethasone and Salicylic Acid)
  Belupo, Poland; Belupo, Slovenia



• Benoson
  Bernofarm, Indonesia



• Betabioptal (Betamethasone and Chloramphenicol)
  Thea-F, Italy



• Betacort
  Pablo Cassara, Argentina; SM Pharma, Venezuela; Trifarma, Peru



• Betacorten
  Trima Unipharm, Singapore



• Betametasona Biocrom
  Biocrom, Argentina



• Betametasona Genfar
  Genfar, Colombia; Genfar, Ecuador



• Betametasona L.CH.
  Chile, Chile



• Betametasona
  McKesson, Ecuador; Mintlab, Chile; Pentacoop, Colombia



• Betametha
  Dojin IyakuTongren, Japan



• Betamethason Norbrook (veterinary use)
  Norbrook, Austria



• Bétaméthasone Arrow
  Arrow, France



• Bétaméthasone Biogaran
  Biogaran, France



• Bétaméthasone EG
  EG Labo, France



• Bétaméthasone Winthrop
  Sanofi-Aventis, France



• Betamethasone Yung Shin
  Yung Shin, Singapore



• Betanoid
  Aspen Pharmacare, South Africa



• Betaselemin (Betamethasone and Dexchlorpheniramine)
  Towa Yakuhin, Japan



• Betason
  Kimia Farma, Indonesia



• Betasone
  Julphar, Oman



• Betasone-G
  Klonal, Argentina



• Betazon
  Jadran, Croatia (Hrvatska)



• Betnelan
  GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Brazil; GlaxoSmithKline, India; GlaxoSmithKline, Iran; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Philippines; GlaxoSmithKline, Qatar; UCB, Ireland; UCB Pharma, United Kingdom



• Betnesol
  GlaxoSmithKline, Luxembourg



• Betsolan (veterinary use)
  Schering-Plough, Ireland; Schering-Plough Vet, Netherlands; Schering-Plough Veterinary, United Kingdom



• Biorinil (Betamethasone and Tetryzoline)
  Thea, Italy



• Brumeton Colloidale S (Betamethasone and Sulfacetamide)
  Bruschettini, Italy



• Butasona Fabra
  Fabra, Argentina



• Celesemine (Betamethasone and Dexchlorpheniramine)
  Schering-Plough, Spain



• Celestamine
  Essex, Germany



• Celestamine (Betamethasone and Dexchlorpheniramine)
  Schering-Plough, Indonesia; Schering-Plough, Japan; Schering-Plough, South Africa



• Célestamine (Betamethasone and Dexchlorpheniramine)
  Schering-Plough, France



• Celestana (Betamethasone and Dexchlorpheniramine)
  Kobayashi Kako, Japan



• Célestène
  Schering-Plough, France; Schering-Plough, Tunisia



• Celestoderm
  Schering-Plough, Latvia



• Celestone S Coloide (Betamethasone and Sulfacetamide)
  Schering-Plough, Spain



• Celestone
  Essex, Colombia; Essex Chemie, Switzerland; Profesa, Ecuador; Schering, Guyana; Schering, United States; Schering-Plough, Argentina; Schering-Plough, Belgium; Schering-Plough, Bulgaria; Schering-Plough, Brazil; Schering-Plough, Costa Rica; Schering-Plough, Dominican Republic; Schering-Plough, Ethiopia; Schering-Plough, Guatemala; Schering-Plough, Honduras; Schering-Plough, Italy; Schering-Plough, Luxembourg; Schering-Plough, Mexico; Schering-Plough, Nicaragua; Schering-Plough, Netherlands; Schering-Plough, Oman; Schering-Plough, Panama; Schering-Plough, Peru; Schering-Plough, Philippines; Schering-Plough, Portugal; Schering-Plough, El Salvador; Schering-Plough, Venezuela; Schering-Plough, South Africa



• Chlocodemin (Betamethasone and Dexchlorpheniramine)
  Taisho Yakuhin, Japan



• Cidoten
  White's, Chile



• Coid
  Lamsa, Argentina



• Colergis (Betamethasone and Dexchlorpheniramine)
  Dexa Medica, Indonesia



• Coritex
  Bago, Chile



• Cortamine (Betamethasone and Dexchlorpheniramine)
  Interbat, Indonesia



• Corteroid
  Montpellier, Argentina



• Cortibet
  Junin, Peru



• Cortixyl Depot
  Bristol-Myers Squibb, Peru



• Daivobet (Betamethasone and Calcipotriol)
  CSL, Australia; Darya-Varia, Indonesia; Pharmagan, Slovenia



• Daivobet (Betamethasone and Calcitonine)
  Leo, Poland



• Deltalaf
  Lanpharm, Argentina



• Dermesone
  Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Jordan; Dar-Al-Dawa, Kuwait; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Qatar; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Somalia; Dar-Al-Dawa, Yemen



• Dermosone
  Opalia, Tunisia



• Diprofos
  Schering-Plough, Portugal



• Diprogenta (Betamethasone and Gentamicin)
  Schering-Plough, Poland; Schering-Plough, Slovenia



• Diprosalic (Betamethasone and Salicylic Acid)
  EU-Pharma, Netherlands; Euro, Netherlands; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Netherlands; Schering-Plough, Poland; Schering-Plough, Slovenia



• Diprosone
  Schering-Plough, Tunisia



• Diprostène
  Schering-Plough, Tunisia



• Emperacin (Betamethasone and Dexchlorpheniramine)
  Medisa Shinyaku, Japan



• Exabet
  Fahrenheit, Indonesia



• Exabetin (Betamethasone and Dexchlorpheniramine)
  Fahrenheit, Indonesia



• Eyebet
  Incepta, Bangladesh



• Fluororinil (Betamethasone and Chlorphenamine)
  Thea-F, Italy



• Fucicort (Betamethasone and Fusidic Acid)
  Leo, Slovakia



• Fuciderm (Betamethasone and Fusidic Acid (veterinary use))
  Leo Pharma Animal, Norway



• Fungolisin NF (Betamethasone and Clotrimazole)
  Farbioquimsa, Peru



• Histablock (Betamethasone and Dexchlorpheniramine)
  Kyowa Yakuhin, Japan



• Kuterid G (Betamethasone and Gentamicin)
  Lek, Slovenia



• Kuterid S (Betamethasone and Salicylic Acid)
  Lek, Slovenia



• Medobeta
  Medochemie, Sri Lanka



• Multiderm
  Farmindustria, Peru



• Nilacelin (Betamethasone and Dexchlorpheniramine)
  Nicholas, Indonesia



• Norbet (veterinary use)
  Norbrook, United Kingdom



• Ocuson (Betamethasone and Dexchlorpheniramine)
  Sanbe, Indonesia



• Persivate
  Aspen Pharmacare, South Africa



• Puradesmin (Betamethasone and Dexchlorpheniramine)
  Taiyo Pharmaceutical, Japan



• Rinderon
  Shionogi Seiyaku, Japan



• Rinesteron
  Fuso Pharmaceutical, Japan



• Saccortin (Betamethasone and Dexchlorpheniramine)
  Nichi-Iko PharmaceuticalJMA, Japan



• Seroderm
  Casel, Turkey



• Steromien
  Aspen Pharmacare, South Africa



• Suprasone
  West Pharma, Tunisia



• Suprastene
  West Pharma, Tunisia



• Tanderil
  Incobra, Colombia



• Topiderm
  Farmindustria, Peru



• Valecort
  Pharmaderm, Tunisia



• Walacort
  Wallace, India



• Xamiol (Betamethasone and Calcipotriol)
  Leo Pharma, Luxembourg



• Zestam (Betamethasone and Dexchlorpheniramine)
  Kalbe, Indonesia



• Beprospen
  Biotech, Venezuela



• Betasone (veterinary use)
  Schering-Plough Animal Health, United States



• Celestone
  Schering, United States



• Cronocorteroid
  Montpellier, Argentina



• Cronolevel
  Essex, Chile; Schering-Plough, Argentina; Schering-Plough, Mexico



• Dexacort Depot
  Sanitas, Peru



• Diprofos
  Plough, Colombia



• Dipronova
  Unipharm, Guatemala; Unipharm, Honduras; Unipharm, Mexico; Unipharm, Nicaragua; Unipharm, El Salvador



• Diprophos
  Aesca, Austria; Essex Chemie, Switzerland; Schering-Plough, Belgium; Schering-Plough, Bahrain; Schering-Plough, Czech Republic; Schering-Plough, Hungary; Schering-Plough, Luxembourg; Schering-Plough, Malta; Schering-Plough, Poland; Schering-Plough, Romania; Schering-Plough, Serbia



• Diprosan
  Schering-Plough, Mexico



• Diprosone Depot
  Essex, Germany



• Diprospan Inyectable
  Essex, Chile



• Diprospan
  Schering-Plough, Brazil; Schering-Plough, China; Schering-Plough, Denmark; Schering-Plough, Hong Kong; Schering-Plough, Israel; Schering-Plough, Iceland; Schering-Plough, Thailand; Schering-Plough, Turkey; Schering-Plough, Venezuela; Undra, Colombia



• Diprostène
  Schering-Plough, France



• Flosteron
  Krka, Bosnia & Herzegowina; Krka, Georgia; Krka, Croatia (Hrvatska); Krka, Slovenia



• Propiochrone
  Schering-Plough, Greece



• Valerpan
  Gutis, Costa Rica; Gutis, Dominican Republic; Gutis, Ecuador; Gutis, Nicaragua; Gutis, Panama; Gutis, El Salvador



• Akriderm
  Akrihin, Russian Federation



• Akriderm Genta (Betamethasone and Gentamicin)
  Akrihin, Russian Federation



• Akriderm SK (Betamethasone and Salicylic Acid)
  Akrihin, Russian Federation



• Alphatrex
  Savage, United States



• Anflavate
  Maeda Yakuhin, Japan



• Antebate
  Torii Yakuhin, Japan



• Beconase
  GlaxoSmithKline, Cayman Islands



• Bedicort G (Betamethasone and Gentamicine Sulfate)
  Jelfa, Poland



• Beloderm
  Belupo, Bosnia & Herzegowina; Belupo, Czech Republic; Belupo, Croatia (Hrvatska); Belupo, Poland; Belupo, Serbia; Belupo, Russian Federation; Belupo, Slovenia; Belupo, Slovakia



• Belogent (Betamethasone and Gentamicine)
  Belupo, Croatia (Hrvatska); Belupo, Poland; Belupo, Slovakia



• Belosalic (Betamethasone and Salicylic Acid)
  Belupo, Croatia (Hrvatska)



• Beprogel
  Hoe, Sri Lanka; Hoe, Myanmar; Hoe, Singapore; Hoe Pharmaceuticals, Ethiopia



• Beprosone
  Hoe, Sri Lanka; Hoe, Singapore; Hoe Pharmaceuticals, Ethiopia



• Beta Micoter (Betamethasone and Clotrimazole)
  Leo Pharma, Spain



• Betacort
  Pablo Cassara, Argentina



• Betacrem
  Hersil, Peru



• Betaderm
  Atco Laboratories, Ethiopia; Eipico Egyptian International Pharmaceutical Industries CO, Ethiopia



• Betadermic (Betamethasone and Salicylic Acid)
  Galenpharma, Germany



• Betamesol
  Proge, Italy; Proge, Malta



• Betametasona Dipropionato L.CH.
  Chile, Chile



• Betametasona Genfar
  Genfar, Peru



• Betametasona Lch
  Ivax, Peru



• Betametasona MK
  MK, Colombia



• Betametasona
  Bago, Chile; Ecuaquímica, Ecuador; Farmindustria, Peru; G&R, Peru; Iqfarma, Peru; Marfan, Peru; Mintlab, Chile; Quilab, Peru; Roxfarma, Peru; Sanitas, Chile; Spefar, Venezuela



• Betametasone Dipropionato C&RF
  C&RF, Italy



• Betametasone Dipropionato Ecobi
  Ecobi, Italy



• Betametasone Dipropionato Sandoz
  Sandoz, Italy



• Betamethason Hexal comp. (Betamethasone and Salicylic Acid)
  Hexal, Germany



• Betamethasone Dipropionate
  Actavis, United States; Fougera, United States; Glenmark, United States; Nycomed, United States; Perrigo, United States; Taro, United States; Teva USA, United States; Tolmar, United States; Warrick, United States



• Beta-Micoter
  Leo, Portugal



• Betamil
  E Merck, Sri Lanka



• Betasin (Betamethasone and Gentamicin)
  Otto, Indonesia



• Betasone
  Hovid, Ethiopia



• Betatopic
  Andromaco, Argentina



• Betazol (Betamethasone and Miconazole)
  Jamjoom Pharma, Oman



• Blacor
  LKM, Argentina



• Clipper
  Chiesi, Spain



• Clotrasone (Betamethasone and Clotrimazole)
  Desarrollos, Spain; Schering-Plough, Denmark



• Clotrimazole and Betamethasone dipropionate (Betamethasone and Clotrimazole)
  Actavis, United States; Nycomed, United States; Taro, United States



• Cortimax
  AC Farma, Peru



• Cortispec
  Euroderm, Argentina



• Cortixyl
  Bristol-Myers Squibb, Peru



• Cremirit
  Mintlab, Chile



• Daivobet
  Leo, Bahrain



• Daivobet (Betamethasone and Betamethasone)
  Leo Pharma, Germany



• Daivobet (Betamethasone and Calcipotriol)
  Leo, Switzerland; Leo, Finland; Leo, France; Leo, Norway; Leo, Sweden; LEO Pharma, Denmark; LEO Pharma, Spain; LEO Pharma, Indonesia



• Dermizol
  Roux-Ocefa, Argentina



• Dermosol-DP
  Iwaki Seiyaku, Japan



• Digenta (Betamethasone and Gentamicin)
  Interbat, Indonesia



• Diprocel
  Sato Seiyaku, Japan; Schering-Plough, Hong Kong; Schering-Plough, Malaysia; Schering-Plough, Singapore; Schering-Plough, Venezuela



• Diproderm
  Aesca, Austria; Eurim, Austria; Lansier, Peru; Schering-Plough, Denmark; Schering-Plough, Spain; Schering-Plough, Finland; Schering-Plough, Iceland; Schering-Plough, Norway; Schering-Plough, Sweden



• Diproform (Betamethasone and Clioquinol)
  Schering-Plough, Italy



• Diproforte
  Aesca, Austria



• Diprogenta
  Aesca, Austria



• Diprogenta (Betamethasone and Gentamicin)
  Essex, Germany; Essex Chemie, Switzerland; Schering-Plough, Spain; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Indonesia; Schering-Plough, South Africa



• Diprolen
  Essex Chemie, Switzerland; Schering-Plough, Denmark; Schering-Plough, Finland; Schering-Plough, Sweden



• Diprolene Glycol
  Schering-Plough, Canada



• Diprolene
  Essex, Chile; Schering, Guyana; Schering, United States; Schering-Plough, Belgium; Schering-Plough, Bahrain; Schering-Plough, Israel; Schering-Plough, Luxembourg; Schering-Plough, Netherlands; Schering-Plough, Oman; Schering-Plough, Philippines; Schering-Plough, Poland; Schering-Plough, Turkey



• Diprolène
  Schering-Plough, France



• Diprosalic
  Aesca, Austria; Eurim, Austria; Schering, Georgia; Schering-Plough, Bahrain; Schering-Plough, Czech Republic; Schering-Plough, Iceland; Schering-Plough, Luxembourg; Schering-Plough, Norway; Schering-Plough, Peru; Schering-Plough, Slovakia



• Diprosalic (Betamethasone and Salicylic Acid)
  Essex, Germany; Essex Chemie, Switzerland; Farmaceutica, Spain; Schering-Plough, Belgium; Schering-Plough, Canada; Schering-Plough, Denmark; Schering-Plough, Finland; Schering-Plough, France; Schering-Plough, United Kingdom; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Indonesia; Schering-Plough, Italy; Schering-Plough, Oman; Schering-Plough, Sweden; Schering-Plough, South Africa



• Diprosis
  Essex, Germany



• Diprosone
  Essex, Germany; Essex Chemie, Switzerland; EU-Pharma, Netherlands; Euro, Netherlands; Key, Colombia; Schering-Plough, Argentina; Schering-Plough, Australia; Schering-Plough, Belgium; Schering-Plough, Bulgaria; Schering-Plough, Bahrain; Schering-Plough, Brazil; Schering-Plough, Canada; Schering-Plough, Czech Republic; Schering-Plough, Ethiopia; Schering-Plough, France; Schering-Plough, United Kingdom; Schering-Plough, Hong Kong; Schering-Plough, Indonesia; Schering-Plough, Ireland; Schering-Plough, Israel; Schering-Plough, Italy; Schering-Plough, Kenya; Schering-Plough, Luxembourg; Schering-Plough, Malta; Schering-Plough, Malaysia; Schering-Plough, Netherlands; Schering-Plough, New Zealand; Schering-Plough, Oman; Schering-Plough, Peru; Schering-Plough, Philippines; Schering-Plough, Poland; Schering-Plough, Portugal; Schering-Plough, Singapore; Schering-Plough, Slovenia; Schering-Plough, Thailand; Schering-Plough, Taiwan; Schering-Plough, Venezuela; Schering-Plough, South Africa



• Diprospan
  Essex, Chile



• Diprotop
  Schering-Plough, Thailand



• Diprovate
  Ranbaxy, Sri Lanka



• Disopranil
  Prater, Chile



• Dovobet (Betamethasone and Betamethasone)
  Leo, Belgium



• Dovobet (Betamethasone and Calcipotriol)
  Adcock Ingram Pharmaceuticals, South Africa; Formenti, Italy; Leo, Canada; Leo, Greece; Leo, Ireland; Leo, Netherlands; Leo Pharma, United Kingdom; Leo Pharma, Luxembourg



• DPPollon
  Mayado Seiyaku, Japan



• Eleuphrat
  Schering-Plough, Australia



• Floderm
  Teikoku Seiyaku, Japan



• Helpoderm
  Help, Greece



• Hizubot
  Tatsumi Kagaku, Japan



• Kuterid
  Lek, Bosnia & Herzegowina; Lek, Czech Republic; Lek, Croatia (Hrvatska); Lek, Poland; Lek, Slovenia; Sandoz, Slovakia



• Labosona
  Labomed, Chile



• Lotricomb (Betamethasone and Clotrimazol)
  Essex, Germany



• Lotriderm (Betamethasone and Clotrimazole)
  Pliva Pharma, United Kingdom; Schering, Belgium; Schering-Plough, Canada; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Indonesia; Schering-Plough, Oman; Schering-Plough, Slovakia; Schering-Plough, South Africa



• Lotrisone (Betamethasone and Clotrimazole)
  Schering, United States



• Maxivate
  Westwood Squibb, United States



• Oftasona P
  Nicolich, Peru



• Opizole (Betamethasone and Clotrimazole)
  Oman Pharmaceutical Products - OPP, Oman



• Oviskin
  Kalbe, Indonesia



• Prevason
  Oman Pharmaceutical Products - OPP, Oman



• Propioform
  Schering-Plough, Greece



• Proson
  Bernofarm, Indonesia



• Psorcutan Beta (Betamethasone and Calcipotriol)
  Intendis, Germany



• Quiacort
  Euroderm, Argentina



• ratio-Topilene
  ratiopharm, Canada



• ratio-Topisalic (Betamethasone and Salicylic Acid)
  ratiopharm, Canada



• ratio-Topisone
  ratiopharm, Canada



• Rinderon-DP
  Shionogi Seiyaku, Japan



• Salibet (Betamethasone and Salicylic Acid)
  Jamjoom Pharma, Oman



• Scanderma
  Tempo Scan Pacific, Indonesia



• Septon
  Shionogi, Taiwan



• Sinacort
  Ibn Sina, Bangladesh



• Soderm plus (Betamethasone and Salicylic Acid)
  Dermapharm, Germany



• Soluderme
  Schering-Plough, Portugal



• Taclonex (Betamethasone and Calcipotriol)
  Leo, United States



• Taro-Sone
  Taro, Canada



• Verilona
  Derma 3, Peru



• Viltern
  Drag Pharma, Chile



• Xamiol (Betamethasone and Calcipotriol)
  Leo, Switzerland; Leo, France; Leo, Ireland; Leo, Sweden; Leo Pharma, Germany; Leo Pharma, United Kingdom



• Beben
  Johnson & Johnson, Italy



• Beben Clorossina (Betamethasone and Chloroxine)
  Johnson & Johnson, Italy



• Topicasone
  Franco-Indian, India



• Adco-Betamethasone
  Adcock Ingram Pharmaceuticals, South Africa



• Alergical Crema (Betamethasone and Fluocinolone Acetonide)
  Iquinosa, Spain



• Alpider (Betamethasone and Fusidic Acid)
  Velka, Greece



• Antroquoril
  Schering-Plough, Australia



• Asisone
  Asiatic Lab, Bangladesh



• Bectmiran
  Towa Yakuhin, Japan



• Bemetson
  Orion, Finland



• Bemon
  Riemser, Germany



• Benoson G (Betamethasone and Gentamicin)
  Bernofarm, Indonesia



• Benoson M (Betamethasone and Miconazole)
  Bernofarm, Indonesia



• Berloson-N (Betamethasone and Neomycin)
  Berlico Mulia Farma, Indonesia



• Besone
  Atlantic, Singapore



• Bestflan (Betamethasone and Neomycin)
  Sawai Seiyaku, Japan



• Bet Fu (Betamethasone and Fusidic Acid)
  Medimar, Greece



• Beta Cream
  Pacific, New Zealand



• Beta Ointment
  Pacific, New Zealand



• Beta Scalp Application
  Pacific, New Zealand



• Béta Septigen (Betamethasone and Gentamicin (veterinary use))
  Intervet, France



• Betacap
  Dermal, United Kingdom; Dermal, Ireland



• Betacort (Betamethasone and Fusidic Acid)
  Biospray, Greece



• Betacorten
  Trima, Israel



• Betacream (Betamethasone and Gentamicin)
  Epifarma, Italy



• BetaCreme KSK
  KSK-Pharma, Germany



• BetaCreme Lichtenstein
  Winthrop, Germany



• Betaderm
  Biotech, Venezuela; E.I.P.I.C.O., Romania; Eipico, United Arab Emirates; Eipico, Bahrain; Eipico, Egypt; Eipico, Iraq; Eipico, Jordan; Eipico, Kuwait; Eipico, Lebanon; Eipico, Libya; Eipico, Oman; Eipico, Oman; Eipico, Qatar; Eipico, Saudi Arabia; Eipico, Sudan; Eipico, Yemen; Taro, Canada



• Betafoam
  Cipla, India



• Betafusin (Betamethasone and Fusidic Acid)
  Pharmex, Greece



• Betagalen
  Galenpharma, Germany



• Betagen (Betamethasone and Gentamicin (veterinary use))
  Med Pharmex, United States



• BetaLotio Winthrop
  Winthrop, Germany



• Betamatic
  Medichrom, Greece



• Betamed
  Medpharma, Bahrain; Medpharma, Oman



• Betameson
  Square, Bangladesh



• Betamet
  Spimaco, Bahrain



• Betametasona Ahimsa
  Ahimsa, Argentina



• Betametasona Biocrom
  Biocrom, Argentina



• Betametasona L.D.A.
  L.D.A., Argentina



• Betametasona Lafedar
  Lafedar, Argentina



• Betametasona MK
  Bonima, Belize; Bonima, Costa Rica; Bonima, Dominican Republic; Bonima, Guatemala; Bonima, Honduras; Bonima, Nicaragua; Bonima, Panama; Bonima, El Salvador



• Betametasona
  Andromaco, Chile; Merck, Ecuador



• Betamethason PCH
  Pharmachemie, Netherlands



• Betamethason Ratiopharm
  ratiopharm, Netherlands



• Betamethason Sandoz
  Sandoz, Netherlands



• Betamethason
  Fagron, Netherlands



• Betamethasone MK
  MK Pharmaceuticals, Aruba; MK Pharmaceuticals, Belize; MK Pharmaceuticals, Jamaica



• Betamethasone Valerate
  Fougera, United States; Paddock, United States; Taro, United States



• Betariem
  Riemser, Germany



• BetaSalbe KSK
  KSK-Pharma, Germany



• BetaSalbe Lichenstein
  Winthrop, Germany



• Betasid (Betamethasone and Fusidic Acid)
  Phoinix Pharm, Greece



• Betasone
  DHA, Singapore; Julphar, Bahrain; Julphar, Oman; Klonal, Argentina



• Betason-N (Betamethasone and Neomycin)
  Kimia Farma, Indonesia



• Betatape
  Faran Laboratories, Greece



• Betatrex
  Savage, United States



• Betaval
  APM, United Arab Emirates; APM, Iraq; APM, Jordan; APM, Kuwait; APM, Lebanon; APM, Libya; APM, Nigeria; APM, Qatar; APM, Saudi Arabia; APM, Sudan; APM, Syria; APM, Yemen; Arab Pharmaceutical Manufacturing, Bahrain; Arab Pharmaceutical Manufacturing Co. LTD. - APM, Oman



• Beta-Val
  Teva USA, United States



• Betaval-N (Betamethasone and Neomycin)
  Arab Pharmaceutical Manufacturing Co. LTD. - APM, Oman



• Betavate
  Drug International, Bangladesh



• Betesil
  Genévrier, France; Genus, United Kingdom; IBSA, Hungary; IBSA, Italy



• Betnelan V
  GlaxoSmithKline, Luxembourg



• Betnelan
  GlaxoSmithKline, Belgium; GlaxoSmithKline, Netherlands



• Betnesalic (Betamethasone and Salicylic Acid)
  GlaxoSmithKline, France



• Betnesol (veterinary use)
  UCB, United Kingdom



• Betnesol-V
  GlaxoSmithKline, Germany



• Betneval
  GlaxoSmithKline, France



• Betnevate N (Betamethasone and Neomycin)
  GlaxoSmithKline, Japan



• Betnevate
  GlaxoSmithKline, Japan



• Betnoval G (Betamethasone and Gentamicin)
  Sato Seiyaku, Japan



• Betnovat
  GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Iceland; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden



• Betnovat (Betamethasone and Clioquinol)
  GlaxoSmithKline, Denmark



• Betnovat (veterinary use)
  GlaxoSmithKline Vet, Norway



• Betnovat med chinoform (Betamethasone and Clioquinol)
  GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden



• Betnovate C (Betamethasone and Clioquinol)
  GlaxoSmithKline, New Zealand



• Betnovate
  Chemidex, United Kingdom; Glaxo Wellcome, Portugal; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Argentina; GlaxoSmithKline, Austria; GlaxoSmithKline, Aruba; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Barbados; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Colombia; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Estonia; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Greece; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Honduras; GlaxoSmithKline, Ireland; GlaxoSmithKline, India; GlaxoSmithKline, Iran; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Panama; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Qatar; GlaxoSmithKline, Singapore; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Vietnam; Sekpharma, South Africa; Sigma, Australia; UCB, Spain



• Betnovate-C (Betamethasone and Clioquinol)
  GlaxoSmithKline, Switzerland; GlaxoSmithKline, Greece; GlaxoSmithKline, Poland



• Betnovate-N (Betamethasone and Neomycin)
  GlaxoSmithKline, Greece; GlaxoSmithKline, Poland



• Betodermin
  Mugi Laboratories, Indonesia



• Betonate
  Shaphaco, Bahrain; Shaphaco, Oman



• Betopic
  Armoxindo, Indonesia



• Bettamousse
  Botniapharma, Finland; Evans, Israel; Focus, United Kingdom; Mipharm, Italy; UCB, Denmark; UCB, Spain; UCB, Ireland; UCB, Norway; Vitaflo, Sweden



• Bevalex (Betamethasone and Neomycin)
  Molex Ayus, Indonesia



• Bevason
  Oman, Bahrain



• Bevason (Betamethasone and Neomycin)
  Oman Pharmaceutical Products - OPP, Oman



• Blamy
  Duncan, Argentina



• Buccobet
  DB, France



• Butasona Fabra
  Fabra, Argentina



• Calamiraderon
  Fukuchi Seiyaku, Japan



• Camnovate
  Camden, Singapore



• Celestan
  Essex, Germany



• Celestoderm Gentamicina (Betamethasone and Gentamicin)
  Key, Spain



• Celestoderm
  Essex Chemie, Switzerland; Key, Colombia; Schering, Georgia; Schering-Plough, Bahrain; Schering-Plough, Estonia; Schering-Plough, Finland; Schering-Plough, Venezuela



• Célestoderm
  Schering-Plough, France



• Celestoderm-V with Garamycin (Betamethasone and Gentamicin)
  Schering-Plough, Finland; Schering-Plough, Greece; Schering-Plough, Indonesia



• Celestoderm-V
  Key, Spain; Schering, Lithuania; Schering-Plough, Greece; Schering-Plough, Kenya; Schering-Plough, Turkey



• Celeston valerat
  Schering-Plough, Denmark; Schering-Plough, Sweden



• Celeston valerat (veterinary use)
  Schering-Plough, Sweden



• Celestonvalerat (Betamethasone and Gentamycin (veterinary use))
  Schering-Plough, Sweden



• Celestonvalerat (Betamethasone and Neomycin (veterinary use))
  Schering-Plough, Sweden



• Celestone
  Schering-Plough, Australia



• Cidoten-V
  White's, Chile



• Cilestoderme
  Schering-Plough, Portugal



• Cordes Beta
  Ichthyol, Germany



• Corsaderm
  Corsa Industries, Indonesia



• Corteroid
  Montpellier, Argentina



• Cortiderma
  Mertens, Argentina



• Cortiflam
  Mediolanum, Italy



• Cortival
  Fawns & McAllan, Australia



• Debion-VG (Betamethasone and Gentamicin)
  Choseido Pharmaceutical, Japan



• Deflatop
  Astellas, Germany



• Dermabet
  Taro, United States



• Dermabiolene (Betamethasone and Gentamicin)
  Farmacologico, Italy



• Dermasone
  ICM, Singapore



• Dermesone
  Dar-Al-Dawa, Oman



• Dermocort
  Sopharma, Bulgaria



• Dermosol
  Iwaki Seiyaku, Japan



• Dermosol-G (Betamethasone and Gentamicin)
  Iwaki Seiyaku, Japan



• Derzid
  Unison, Singapore



• Dexan G (Betamethasone and Gentamicin)
  Fuji Yakuhin, Japan



• Dexan-VG (Betamethasone and Gentamicin)
  Fuji Yakuhin, Japan



• Ecoval
  GlaxoSmithKline, Italy



• Ecoval (Betamethasone and Neomycin)
  GlaxoSmithKline, Italy



• Egerian (Betamethasone and Gentamicin)
  AGIPS, Italy



• Fidagenbeta (Betamethasone and Gentamicin)
  Fidia, Italy



• Flogozyme
  Norma, Greece



• Fubecot (Betamethasone and Fusidic Acid)
  Target Pharma, Greece



• Fucibet (Betamethasone and Fusidic Acid)
  Leo Pharma, Spain; Leo Pharma, United Kingdom



• Fucicort (Betamethasone and Fusidic Acid)
  CSL Biotherapies, New Zealand; Darya-Varia, Indonesia; Formenti, Italy; Leo, Belgium; Leo, Bahrain; Leo, Switzerland; Leo, Finland; Leo, Greece; Leo, Luxembourg; Leo, Oman; Leo Pharma, Germany; Leo Pharma, Denmark; Leo Pharma, Indonesia



• Fucicort Lipid (Betamethasone and Fusidic Acid)
  Leo, Finland



• Fucicream (Betamethasone and Fusidic Acid)
  A.G. Therapy, Greece



• Fuciderm (Betamethasone and Fusidate sodium (veterinary use))
  Dechra, Austria



• Fuciderm (Betamethasone and Fusidic Acid (veterinary use))
  Bayer Animal, Germany; Bayer Animal, New Zealand; Bayer Australia Ltd Animal Health, Australia; Gräub, Switzerland; Vetxx, Finland; Vetxx, Norway; Vetxx, Sweden



• Fusibact B (Betamethasone and Fusidic Acid)
  Jamjoom Pharma, Oman



• Fusibet (Betamethasone and Fusidic Acid)
  S.M. Farm, Greece



• Futasone (Betamethasone and Fusidic Acid)
  Julphar, Bahrain; Julphar, Oman



• Galinocort
  Vilco, Greece



• Gentalyn Beta (Betamethasone and Gentamicin)
  Schering-Plough, Italy



• Gentamicin Sulfate (Betamethasone and Gentamicin (veterinary use))
  First Priority, United States



• Gentamicina + Betametasone ABC (Betamethasone and Gentamicin)
  ABC, Italy



• Gentamicina + Betametasone Actavis (Betamethasone and Gentamicin)
  Actavis, Italy



• Gentamicina + Betametasone Almus (Betamethasone and Gentamicin)
  Almus, Italy



• Gentamicina + Betametasone Alter (Betamethasone and Gentamicin)
  Alter, Italy



• Gentamicina + Betametasone EG (Betamethasone and Gentamicin)
  EG, Italy



• Gentamicina + Betametasone Germed (Betamethasone and Gentamicin)
  Germed Pliva, Italy



• Gentamicina + Betametasone Hexal (Betamethasone and Gentamicin)
  Hexal, Italy



• Gentamicina + Betamet

Pyrazinamide

In the US, Pyrazinamide (pyrazinamide systemic) is a member of the drug class nicotinic acid derivatives and is used to treat Tuberculosis - Active and Tuberculosis - Latent.

US matches:

• Pyrazinamide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AK01

CAS registry number (Chemical Abstracts Service)

0000098-96-4

Chemical Formula

C5-H5-N3-O

Molecular Weight

123

Therapeutic Category

Antitubercular agent

Chemical Name

Pyrazinecarboxamide

Foreign Names

• Pyrazinamidum (Latin)
• Pyrazinamid (German)
• Pyrazinamide (French)
• Pirazinamida (Spanish)

Generic Names

• Pirazinamide (OS: DCIT)
• Pyrazinamide (OS: DCF, JAN, BAN)
• Pyrazinecarboxamide (IS: WHO)
• Pyrazinoic Acid Amide (IS)
• Pyrizinamide (IS)
• Pyrazinamid (PH: Ph. Eur. 6)
• Pyrazinamide (PH: BP 2010, JP XIV, Ph. Int. 4, USP 32, Ph. Eur. 6)
• Pyrazinamidum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Akt-4 (Pyrazinamide and Rifampicin, + Ethambutol, +Isoniazid)
  Lupin, Myanmar



• Akurit-4 (Pyrazinamide and Rifampicin, + Isoniazid, + Ethambutol)
  Lupin, Myanmar



• Akurit-Z (Pyrazinamide and Isoniazid, + Rifampicin)
  Lupin, Myanmar



• Combiblister (Pyrazinamide and Isoniazid + Rifampicin)
  Roemmers, Peru



• Corsazinamid
  Corsa Industries, Indonesia



• Firazin
  Sanofi-Aventis, Bangladesh



• Macrozid
  Macleods Pharmaceuticals, Ethiopia



• Pezeta-Ciba
  Sandoz, Indonesia



• Pharex Pyrazinamide
  Pascual, Philippines



• Phthizopiram (Pyrazinamide and Isoniazid)
  Akrihin, Russian Federation



• Piraldina
  Bracco, Italy



• Pirazinamida Lafedar
  Lafedar, Argentina



• Pirazinamida Prodes
  Almirall, Spain



• Pirazinamida Veinfar
  Veinfar, Argentina



• Pirazinamida
  Antibiotice, Romania; Bestpharma, Chile; Refasa, Peru; Roemmers, Peru



• Pirazinamids
  Olainfarm, Latvia



• Pirazinid
  Kocak, Bosnia & Herzegowina; Koçak, Turkey



• Pirilène
  Sanofi-Aventis, France



• Pramide
  Winthrop, Portugal



• Prazina
  Armoxindo, Indonesia



• Pyrafat
  Fatol, Georgia; Fatol, Lithuania; Riemser, Austria; Riemser, Germany



• Pyramide
  Daiichi Sankyo, Japan



• Pyrazinamid Jenapharm
  Mibe Jena, Germany



• Pyrazinamid Krka
  Krka, Estonia; Krka, Croatia (Hrvatska); Krka, Latvia



• Pyrazinamid Labatec
  Labatec, Switzerland



• Pyrazinamid Lederle
  Riemser, Germany



• Pyrazinamid Medic
  Medic, Denmark



• Pyrazinamid SAD
  Amgros, Denmark



• Pyrazinamid
  ExtractumPharma, Hungary; Farmapol, Poland; Krka, Bosnia & Herzegowina; Krka, Georgia; Krka, Lithuania; Krka, Slovenia; Sigmapharm, Austria



• Pyrazinamid-Akri
  Akrihin, Russian Federation



• Pyrazinamide CF
  Centrafarm, Netherlands



• Pyrazinamide Genepharm
  Genepharm, Greece



• Pyrazinamide PCH
  Pharmachemie, Netherlands



• Pyrazinamide
  AFT, New Zealand; Genuine, Taiwan; Ipca, Russian Federation; Makis Pharma, Russian Federation; Mikart, United States; Pei Li, Taiwan; Pharmadrug, Germany; Pharmamed, Ethiopia; VersaPharm, United States; West-Ward, United States



• Pyrazinamid-PP
  Pannonpharma, Hungary



• Pyzin
  Lupin, India



• Pyzina
  Lupin, India; Lupin, Myanmar



• PZA
  Roemmers, Peru



• PZA-Ciba
  Novartis, Bangladesh; Novartis, India; Promed, Russian Federation; Sandoz, Philippines; Sandoz, Singapore



• P-Zide
  Cadila, India



• Rifafour (Pyrazinamide and Rifampicin, Isoniazid, Ethambutol)
  Aventis, South Africa; Sanofi-Aventis, Thailand



• Rifater (Pyrazinamide and Isoniazid, + Rifampicin)
  Duncan, Philippines; Grünenthal, Germany; Sanofi-Aventis, Austria; Sanofi-Aventis, Canada; Sanofi-Aventis, Switzerland; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Ireland; Sanofi-Aventis, Slovenia; Sanofi-Aventis, Thailand; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States; Sanofi-Aventis S.A., Spain



• Rimactazid (Pyrazinamide and Rifampicin)
  Sandoz, Philippines



• Rimcure (Pyrazinamide and Rifampicin, + Isoniazid)
  Sandoz, Switzerland; Sandoz, Denmark; Sandoz, Spain; Sandoz, Indonesia; Sandoz, Norway; Sandoz, Philippines; Sandoz, Sweden; Sandoz, South Africa



• Rimstar (Pyrazinamide and Rifampicin, + Isoniazid, + Ethambutol)
  Sandoz, Switzerland; Sandoz, Denmark; Sandoz, Spain; Sandoz, Indonesia; Sandoz, Netherlands; Sandoz, Norway; Sandoz, Sweden; Sandoz, South Africa



• Ritemed Pyrazinamide
  Ritemed, Philippines



• Sanazet
  Sanbe, Indonesia



• Sandoz Pyrazinamide
  Sandoz, South Africa



• Siramid
  Mersifarma, Indonesia



• Tebesium TRIO (Pyrazinamide and Rifampicin, Isoniazid)
  Riemser, Germany



• Tebrazid
  Continental, Saudi Arabia; Continental, Sudan; Kela, Belgium; Kela, Luxembourg; Valeant, Canada



• Tisamid
  Orion, Finland



• Zapedia
  Pascual, Philippines



• Zcure
  Natrapharm, Philippines



• Zinaplex
  Pediatrica, Philippines

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Orapred ODT

In the US, Orapred ODT (prednisolone systemic) is a member of the drug class glucocorticoids and is used to treat Asthma - acute, Bullous Pemphigoid, Dermatitis, Immunosuppression, Inflammatory Conditions, Multiple Sclerosis, Nephrotic Syndrome, Pemphigoid and Pemphigus.

US matches:

• Orapred ODT

Ingredient matches for Orapred ODT

Prednisolone

Prednisolone 21-(disodium phosphate) (a derivative of Prednisolone) is reported as an ingredient of Orapred ODT in the following countries:

• United States

International Drug Name Search

Omeprazol Arafarma

Omeprazol Arafarma may be available in the countries listed below.

Ingredient matches for Omeprazol Arafarma

Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Arafarma in the following countries:

• Spain

International Drug Name Search

OB Complete with DHA

Generic Name: prenatal multivitamins (PRE nay tal VYE ta mins)

Brand Names: Advance Care Plus, Bright Beginnings, Cavan Folate, Cavan One, Cavan-Heme OB, Cenogen Ultra, CitraNatal Rx, Co Natal FA, Complete Natal DHA, Complete-RF, CompleteNate, Concept OB, Docosavit, Dualvit OB, Duet, Edge OB, Elite OB 400, Femecal OB, Folbecal, Folcaps Care One, Folivan-OB, Foltabs, Gesticare, Icar Prenatal, Icare Prenatal Rx, Inatal Advance, Infanate DHA, Kolnatal DHA, Lactocal-F, Marnatal-F, Maternity, Maxinate, Mission Prenatal, Multi-Nate 30, Multinatal Plus, Nata 29 Prenatal, Natachew, Natafort, Natelle, Neevo, Nestabs, Nexa Select with DHA, Novanatal, NovaStart, O-Cal Prenatal, OB Complete, OB Natal One, Ob-20, Obtrex DHA, OptiNate, Paire OB Plus DHA, PNV Select, PNV-Total, PR Natal 400, Pre-H-Cal, Precare, PreferaOB, Premesis Rx, PrenaCare, PrenaFirst, PrenaPlus, Prenatabs OBN, Prenatabs Rx, Prenatal 1 Plus 1, Prenatal Elite, Prenatal Multivitamins, Prenatal Plus, Prenatal S, Prenatal-U, Prenate Advanced Formula, Prenate DHA, Prenate Elite, Prenavite FC, PreNexa, PreQue 10, Previte Rx, PrimaCare, Pruet DHA, RE OB Plus DHA, Renate, RightStep, Rovin-NV, Se-Care, Se-Natal One, Se-Plete DHA, Se-Tan DHA, Select-OB, Seton ET, Strongstart, Stuart Prenatal with Beta Carotene, Tandem OB, Taron-BC, Tri Rx, TriAdvance, TriCare, Trimesis Rx, Trinate, Triveen-PRx RNF, UltimateCare Advance, Ultra-Natal, Vemavite PRX 2, VeNatal FA, Verotin-BY, Verotin-GR, Vinacal OR, Vinatal Forte, Vinate Advanced (New Formula), Vinate AZ, Vinate Care, Vinate Good Start, Vinate II (New Formula), Vinate III, Vinate One, Vitafol-OB, VitaNatal OB plus DHA, Vitaphil, Vitaphil Aide, Vitaphil Plus DHA, Vitaspire, Viva DHA, Vol-Nate, Vol-Plus, Vol-Tab Rx, Vynatal F.A., Zatean-CH, Zatean-PN

What are OB Complete with DHA (prenatal multivitamins)?

There are many brands and forms of prenatal vitamin available and not all brands are listed on this leaflet.

Prenatal vitamins are a combination of many different vitamins that are normally found in foods and other natural sources.

Prenatal vitamins are used to provide the additional vitamins needed during pregnancy. Minerals may also be contained in prenatal multivitamins.

Prenatal vitamins may also be used for purposes not listed in this medication guide.

What is the most important information I should know about prenatal vitamins?

There are many brands and forms of prenatal vitamin available and not all brands are listed on this leaflet.

Never take more than the recommended dose of a multivitamin. Avoid taking any other multivitamin product within 2 hours before or after you take your prenatal vitamins. Taking similar vitamin products together at the same time can result in a vitamin overdose or serious side effects.

Many multivitamin products also contain minerals such as calcium, iron, magnesium, potassium, and zinc. Minerals (especially taken in large doses) can cause side effects such as tooth staining, increased urination, stomach bleeding, uneven heart rate, confusion, and muscle weakness or limp feeling. Read the label of any multivitamin product you take to make sure you are aware of what it contains.

Seek emergency medical attention if you think you have used too much of this medicine. An overdose of vitamins A, D, E, or K can cause serious or life-threatening side effects and can also harm your unborn baby. Certain minerals contained in a prenatal multivitamin may also cause serious overdose symptoms or harm to the baby if you take too much.

Overdose symptoms may include stomach pain, vomiting, diarrhea, constipation, loss of appetite, hair loss, peeling skin, tingly feeling in or around your mouth, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine, pale skin, and easy bruising or bleeding.

Do not take this medication with milk, other dairy products, calcium supplements, or antacids that contain calcium. Calcium may make it harder for your body to absorb certain ingredients of the multivitamin.

What should I discuss with my healthcare provider before taking prenatal vitamins?

Many vitamins can cause serious or life-threatening side effects if taken in large doses. Do not take more of this medication than directed on the label or prescribed by your doctor.

Before taking prenatal vitamins, tell your doctor about all of your medical conditions.

You may need to continue taking prenatal vitamins if you breast-feed your baby. Ask your doctor about taking this medication while breast-feeding.

How should I take prenatal vitamins?

Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Never take more than the recommended dose of prenatal vitamins.

Many multivitamin products also contain minerals such as calcium, iron, magnesium, potassium, and zinc. Minerals (especially taken in large doses) can cause side effects such as tooth staining, increased urination, stomach bleeding, uneven heart rate, confusion, and muscle weakness or limp feeling. Read the label of any multivitamin product you take to make sure you are aware of what it contains.

Take your prenatal vitamin with a full glass of water.

Swallow the regular tablet or capsule whole. Do not break, chew, crush, or open it.

The chewable tablet must be chewed or allowed to dissolve in your mouth before swallowing. You may also allow the chewable tablet to dissolve in drinking water, fruit juice, or infant formula (but not milk or other dairy products). Drink this mixture right away.

Use prenatal vitamins regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.

Store at room temperature away from moisture and heat. Keep prenatal vitamins in their original container. Storing vitamins in a glass container can ruin the medication.

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine. An overdose of vitamins A, D, E, or K can cause serious or life-threatening side effects and can also harm your unborn baby. Certain minerals contained in a prenatal multivitamin may also cause serious overdose symptoms or harm to the baby if you take too much.

Overdose symptoms may include stomach pain, vomiting, diarrhea, constipation, loss of appetite, hair loss, peeling skin, tingly feeling in or around your mouth, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine, pale skin, and easy bruising or bleeding.

What should I avoid while taking prenatal vitamins?

Avoid taking any other multivitamin product within 2 hours before or after you take your prenatal vitamins. Taking similar vitamin products together at the same time can result in a vitamin overdose or serious side effects.

Avoid the regular use of salt substitutes in your diet if your multivitamin contains potassium. If you are on a low-salt diet, ask your doctor before taking a vitamin or mineral supplement.

Do not take this medication with milk, other dairy products, calcium supplements, or antacids that contain calcium. Calcium may make it harder for your body to absorb certain ingredients of the prenatal vitamin.

Prenatal vitamins side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

When taken as directed, prenatal vitamins are not expected to cause serious side effects. Less serious side effects may include:

• 
  

  upset stomach;

  
  


• 
  

  headache; or

  
  


• 
  

  unusual or unpleasant taste in your mouth.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect prenatal vitamins?

Vitamin and mineral supplements can interact with certain medications, or affect how medications work in your body. Before taking a prenatal vitamin, tell your doctor if you also use:

• 
  

  diuretics (water pills);

  
  


• 
  

  heart or blood pressure medications;

  
  


• 
  

  tretinoin (Vesanoid);

  
  


• 
  

  isotretinoin (Accutane, Amnesteen, Clavaris, Sotret);

  
  


• 
  

  trimethoprim and sulfamethoxazole (Cotrim, Bactrim, Gantanol, Gantrisin, Septra, TMP/SMX); or

  
  


• 
  

  an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn, Naprelan, Treximet), celecoxib (Celebrex), diclofenac (Cataflam, Voltaren), indomethacin (Indocin), meloxicam (Mobic), and others.

  
  

This list is not complete and other drugs may interact with prenatal vitamins. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More OB Complete with DHA resources

• OB Complete with DHA Use in Pregnancy & Breastfeeding
• OB Complete with DHA Drug Interactions
• OB Complete with DHA Support Group
• 0 Reviews for OB Complete with DHA - Add your own review/rating

• Cal-Nate MedFacts Consumer Leaflet (Wolters Kluwer)


• CareNatal DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• CitraNatal 90 DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• CitraNatal Assure Prescribing Information (FDA)


• CitraNatal Harmony Prescribing Information (FDA)


• Concept DHA Prescribing Information (FDA)


• Docosavit Prescribing Information (FDA)


• Duet DHA with Ferrazone MedFacts Consumer Leaflet (Wolters Kluwer)


• Folbecal MedFacts Consumer Leaflet (Wolters Kluwer)


• Folcal DHA Prescribing Information (FDA)


• Folcaps Care One Prescribing Information (FDA)


• Gesticare DHA Prescribing Information (FDA)


• Gesticare DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• Inatal Advance Prescribing Information (FDA)


• Inatal Ultra Prescribing Information (FDA)


• Multi-Nate DHA Prescribing Information (FDA)


• Multi-Nate DHA Extra Prescribing Information (FDA)


• MultiNatal Plus MedFacts Consumer Leaflet (Wolters Kluwer)


• Natelle One Prescribing Information (FDA)


• Neevo Caplets MedFacts Consumer Leaflet (Wolters Kluwer)


• Neevo DHA MedFacts Consumer Leaflet (Wolters Kluwer)


• OB Complete 400 MedFacts Consumer Leaflet (Wolters Kluwer)


• Paire OB Plus DHA Prescribing Information (FDA)


• PreNexa MedFacts Consumer Leaflet (Wolters Kluwer)


• PreNexa Prescribing Information (FDA)


• PreferaOB Prescribing Information (FDA)


• Prenatal Plus Prescribing Information (FDA)


• Prenatal Plus Iron Prescribing Information (FDA)


• Prenate Elite Prescribing Information (FDA)


• Prenate Elite MedFacts Consumer Leaflet (Wolters Kluwer)


• Prenate Elite tablets


• Prenate Essential Prescribing Information (FDA)


• PrimaCare Advantage MedFacts Consumer Leaflet (Wolters Kluwer)


• PrimaCare ONE capsules


• PrimaCare One MedFacts Consumer Leaflet (Wolters Kluwer)


• Renate DHA Prescribing Information (FDA)


• Se-Natal 19 Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• Se-Natal 19 Prescribing Information (FDA)


• Tandem DHA Prescribing Information (FDA)


• Tandem OB Prescribing Information (FDA)


• TriAdvance Prescribing Information (FDA)


• Triveen-One MedFacts Consumer Leaflet (Wolters Kluwer)


• Triveen-PRx RNF Prescribing Information (FDA)


• UltimateCare ONE NF Prescribing Information (FDA)


• Ultra NatalCare MedFacts Consumer Leaflet (Wolters Kluwer)


• Vinate AZ Prescribing Information (FDA)


• Vitafol-One MedFacts Consumer Leaflet (Wolters Kluwer)


• Zatean-CH Prescribing Information (FDA)

Compare OB Complete with DHA with other medications

• Vitamin/Mineral Supplementation during Pregnancy/Lactation

Where can I get more information?

• Your pharmacist can provide more information about prenatal vitamins.

Molsibeta

Molsibeta may be available in the countries listed below.

Ingredient matches for Molsibeta

Molsidomine

Molsidomine is reported as an ingredient of Molsibeta in the following countries:

• Germany

International Drug Name Search

Rhinocort Aqua eent

Generic Name: Budesonide eent
Class: Corticosteroids
ATC Class: R01AD05
VA Class: NT200
Chemical Name: [11β,16α(R)]-16,17-Butylidene-bis(oxy)-11,21-dihydroxy-pregna-1,4-diene-3,20-dione and 16α,17-[(S)-butylidinebis(oxy)]-11β,21-dihydroxypregna-1,4-diene-3,20-dione
Molecular Formula: C₂₅H₃₄O₆
CAS Number: 51333-22-3

REMS:

FDA approved a REMS for budesonide to ensure that the benefits of a drug outweigh the risks. The REMS may apply to one or more preparations of budesonide and consists of the following: communication plan. See the FDA REMS page () or the ASHP REMS Resource Center ().

Introduction

Synthetic non-halogenated corticosteroid.^{1 16}

Uses for Rhinocort Aqua

Allergic Rhinitis

Symptomatic treatment of seasonal or perennial allergic rhinitis.^{1 7 8 9 12 13 14 15 16 17 18 19}

Rhinocort Aqua Dosage and Administration

General

• 
  

  For therapeutic effectiveness, use at regular intervals.¹

  
  

Administration

Intranasal Inhalation

Administer by nasal inhalation using a metered-dose pump spray.¹

Shake inhaler gently immediately prior to use.^{1 17}

Prior to initial use, the metered-dose pump spray must be primed with 8 actuations.^{1 10}

If spray pump is not used for 2 consecutive days, partially prime (1 actuation or until a fine spray is observed).^{1 17} If the spray pump is not used for more than 14 days, rinse the applicator and reprime with 2 sprays or until a fine spray appears.¹ Rinse the applicator when not used for more than 14 days.^{1 17}

Clear nasal passages prior to administration.^a

Tilt the head slightly forward, insert the spray tip into one nostril, and point the tip toward the back of the nose.^a Pump the drug into one nostril while holding the other nostril closed and concurrently inspire through the nose.^a Repeat this procedure for the other nostril.^a

Dosage

After priming, nasal spray pump delivers about 32 mcg of budesonide per metered spray and about 120 metered doses per 8.6-g container.^{1 10}

Pediatric Patients

Titrate dosage to the lowest possible effective level.¹ (See Pediatric Use under Cautions.)

Seasonal Allergic Rhinitis

Intranasal Inhalation

Children 6–11 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total).^{1 17} May be increased to 64 mcg (2 sprays) in each nostril once daily (128 mcg total).¹

Children ≥12 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total).^{1 17} May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).¹

Perennial Allergic Rhinitis

Intranasal Inhalation

Children 6–11 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total).^{1 17} May be increased to 64 mcg (2 sprays) in each nostril once daily (128 mcg total).¹

Children ≥12 years of age: initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total).^{1 17} May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).¹

Adults

Seasonal Allergic Rhinitis

Intranasal Inhalation

Initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total).^{1 17} May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).¹

Perennial Allergic Rhinitis

Intranasal Inhalation

Initially, 32 mcg (1 spray) in each nostril once daily (64 mcg total).^{1 17} May be increased to 128 mcg (4 sprays) in each nostril once daily (256 mcg total).¹

Prescribing Limits

Pediatric Patients

Seasonal Allergic Rhinitis

Intranasal Inhalation

Children 6–11 years of age: maximum 128 mcg (2 sprays in each nostril) once daily.¹

Children ≥12 years of age: maximum 256 mcg (4 sprays in each nostril) once daily.¹

Perennial Allergic Rhinitis

Intranasal Inhalation

Children 6–11 years of age: maximum 128 mcg (2 sprays in each nostril) once daily.¹

Children ≥12 years of age: maximum 256 mcg (4 sprays in each nostril) once daily.¹

Adults

Seasonal Allergic Rhinitis

Intranasal Inhalation

Maximum 256 mcg (4 sprays in each nostril) once daily.¹

Perennial Allergic Rhinitis

Intranasal Inhalation

Maximum 256 mcg (4 sprays in each nostril) once daily.¹

Special Populations

Hepatic Impairment

No specific dosage recommendations at this time.¹

Renal Impairment

No specific dosage recommendations at this time.¹

Geriatric Patients

No specific dosage recommendations at this time.¹

Cautions for Rhinocort Aqua

Contraindications

• 
  

  Known hypersensitivity to budesonide or any ingredient of the formulation.¹

  
  

Warnings/Precautions

Warnings

Withdrawal of Systemic Corticosteroid Therapy

Possible corticosteroid withdrawal symptoms (e.g., joint pain, muscular pain, lassitude, depression), acute adrenal insufficiency, or severe symptomatic exacerbation of asthma or other clinical conditions if prolonged systemic corticosteroid therapy is replaced with topical corticosteroid therapy; careful monitoring recommended.¹

Use particular caution in patients with associated asthma or other conditions that may be exacerbated by too rapid a reduction in systemic corticosteroid dosage.¹

Immunosuppressed Patients

Increased susceptibility to infections in patients who are taking immunosuppressant drugs.¹ Certain infections (e.g., varicella [chickenpox], measles) can be serious or even fatal in such patients, particularly in children.¹

Exposure to varicella and measles should be avoided in previously unexposed patients.¹ If exposure to varicella (chickenpox) or measles occurs in susceptible patients, consider administering varicella zoster immune globulin (VZIG) or immune globulin (IG) respectively.^{1 10} Consider treatment with an antiviral agent if varicella develops.¹

Sensitivity Reactions

Rarely, immediate or delayed hypersensitivity reactions may occur.^{1 16} Wheezing reported very rarely.¹

General Precautions

Systemic Corticosteroid Effects

Possible growth suppression in children and adolescents.^{1 20} (See Pediatric Use under Cautions.)

Excessive intranasal dosages or use in patients who are particularly sensitive to corticosteroid effects may increase risk of systemic corticosteroid effects (e.g., hypercorticism and adrenal suppression).¹

To minimize the systemic effects, titrate dosage to the lowest possible effective level;¹ avoid use of higher than recommended dosages.¹ If systemic effects occur, slowly reduce dosage and discontinue drug.¹

Nasopharyngeal and Ocular Effects

Rarely, localized candidal infections of the nose and/or pharynx have been reported.¹ Local treatment of such infections and/or discontinuance of intranasal therapy may be required.¹

Rarely, nasal septum perforation and increased intraocular pressure (IOP) have been reported.¹

Periodically examine nasal passages for mucosal changes during long-term therapy (several months or longer).¹

Use not recommended in patients with recent nasal septal ulcers, nasal surgery, or nasal trauma until healing has occurred.¹

Concomitant Infections

Use with caution, if at all, in patients with clinical or asymptomatic Mycobacterium tuberculosis infection of the respiratory tract; in untreated fungal, bacterial, or systemic viral infections; or ocular herpes simplex infections.¹

Specific Populations

Pregnancy

Category B.^{1 a}

Use during pregnancy may result in hypoadrenalism in infants;^{1 a} monitor these infants carefully.^{1 a}

Lactation

Not known whether budesonide is distributed into milk.¹ Caution if used in nursing women.¹

Pediatric Use

Safety and efficacy not established in children <6 years of age.¹

Intranasal corticosteroids may reduce growth velocity in pediatric patients.¹ Routine monitoring of growth (e.g., via stadiometry) recommended.¹ Titrate dosage to the lowest possible effective level.¹

Geriatric Use

No overall substantial differences in safety and efficacy relative to younger patients.¹ However, possible increased sensitivity to the drug.¹ Frequency of epistaxis may increase with age.¹

Hepatic Impairment

Possible decreased clearance and increased systemic availability.¹

Renal Impairment

Pharmacokinetics not studied in patients with renal impairment.¹

Common Adverse Effects

Epistaxis, pharyngitis, bronchospasm, cough, nasal irritation.¹

Interactions for Rhinocort Aqua

Metabolized by CYP3A4 isoenzyme.¹

Drugs Affecting Hepatic Microsomal Enzymes

Potential pharmacokinetic interaction (increased plasma budesonide concentrations) with concomitant use of CYP3A4 isoenzyme inhibitors.¹

Inhibitors of the CYP2C19 isoenzyme do not appear to affect the pharmacokinetics of oral budesonide.¹

Specific Drugs

Drug	Interaction
Cimetidine	Decreased budesonide clearance and increased oral bioavailability1
Clarithromycin	Increased plasma budesonide concentrations1
Erythromycin	Increased plasma budesonide concentrations1
Itraconazole	Increased plasma budesonide concentrations1
Ketoconazole	Increased plasma budesonide concentrations1
Omeprazole	No apparent pharmacokinetic interaction1

Rhinocort Aqua Pharmacokinetics

Absorption

Bioavailability

Relatively well absorbed following intranasal inhalation.¹ Following intranasal administration, approximately 34% of a dose reaches systemic circulation.¹ Mean peak plasma budesonide concentrations are attained in about 0.7 hours.¹

Onset

Nasal symptoms improve within 8–12 hours following initiation of therapy.^{1 7} About 50–66% of the total symptomatic relief is evident within 1–2 days after treatment initiation.¹ May require about 2 weeks of therapy for optimum effectiveness.¹

Special Populations

Children have plasma drug concentrations approximately twice those observed in adults due to differences in weight.¹

Distribution

Extent

Distributes into red blood cells.¹ Not known whether the drug crosses the placenta or distributes into breast milk; however, other corticosteroids are distributed into breast milk.¹

Plasma Protein Binding

85-90%.¹ Little to no binding to glucocorticosteroid binding globulin.¹

Elimination

Metabolism

Rapidly metabolized to metabolites of low corticosteroid potency by CYP3A4.¹

Elimination Route

Excreted in urine (66%) and feces (33%) as metabolites.¹

Half-life

2–3 hours.¹

Special Populations

Hepatic impairment may affect elimination of corticosteroids by increasing the systemic availability of oral budesonide.¹ Intranasally applied budesonide not studied in such patients.¹

Stability

Storage

Intranasal Inhalation

Suspension

20–25°C; do not freeze.¹ Protect from light.¹

Actions

• 
  

  Potent glucocorticoid and weak mineralocorticoid activity.¹

  
  


• 
  

  Decreases the nasal reactivity to allergens and decreases release of inflammatory mediators^{1 4} and proteolytic enzymes.⁴

  
  


• 
  

  Reduces the number of certain mediator cells (basophils,^{5 15} eosinophils,^{1 5 15} T-helper cells,⁶ mast cells,^{1 4} and neutrophils)^{1 5} in the nasal mucosa.

  
  

Advice to Patients

• 
  

  Importance of providing patient a copy of the manufacturer's patient information.^{1 17}

  
  


• 
  

  Importance of understanding proper storage, preparation, and administration techniques.¹ Importance of shaking container gently prior to each use.¹ Importance of avoiding spraying drug into the eyes.^{1 17}

  
  


• 
  

  Advise patients that containers of budesonide nasal spray should be discarded after 120 actuations.¹

  
  


• 
  

  Importance of regular use to obtain therapeutic effectiveness.¹ Importance of not exceeding prescribed dosage.¹

  
  


• 
  

  Advise that the drug usually will provide symptomatic relief within 2 days, but 2 weeks of continuous therapy usually are required for optimum effects.¹

  
  


• 
  

  Importance of informing clinician if symptoms worsen or fail to improve within 2 weeks.¹

  
  


• 
  

  Importance of advising clinician if recurrent epistaxis or nasal septum discomfort occurs.¹

  
  


• 
  

  Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs.¹

  
  


• 
  

  Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.¹

  
  


• 
  

  Importance of informing patients of other important precautionary information. (See Cautions.)

  
  

Preparations

Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.

In 2002, the manufacturer decided to gradually phase out budesonide nasal aerosol (Rhinocort)² from the US market.³ AstraZeneca will continue to manufacture budesonide nasal spray (Rhinocort Aqua) that unlike budesonide nasal aerosol does not contain fluorocarbons which have been associated with excessive drying of the nasal mucosa in some patients.¹¹

Budesonide

Routes	Dosage Forms	Strengths	Brand Names	Manufacturer
Nasal	Suspension, for intranasal use only	32 mcg/metered spray	Rhinocort Aqua Nasal Spray	AstraZeneca

Comparative Pricing

This pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 10/2011. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays.

Rhinocort Aqua 32MCG/ACT Suspension (ASTRAZENECA LP): 9/$115.99 or 26/$329.99

Disclaimer

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.

The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions October 27, 2011. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.

References

1. AstraZeneca. Rhinocort Aqua (budesonide nasal spray) prescribing information. Wilmington, DE; 2001 Oct.

2. AstraZeneca. Rhinocort (budesonide nasal inhaler) prescribing information (dated 2001 Apr). In: Physicians' desk reference. 56th ed. Montvale, NJ: Medical Economics Company Inc; 2002:640-2.

3. Anon. Dear Pharmacist letter concerning discontinuance of the manufacture of Rhinocort (budesonide nasal inhaler). Wilmington, DE: AstraZeneca; 2002 Nov 15.

4. Meltzer EO, Jalowayski AA, Field EA et al. Intranasal fluticasone propionate reduces histamine and tryptase in the mucosa of allergic rhinitis patients. J Allergy Clin Immunol. 1993; 91:298.

5. Bryson HM, Faulds D. Intranasal fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs. 1992; 43:760-75. [IDIS 359172] [PubMed 1379151]

6. Masuyama K, Jacobson MR, Rak S et al. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology. 1994; 82:192- 9. [PubMed 7927488]

7. Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Ann Allergy Asthma Immunol. 2002; 89:279-84. [IDIS 486624] [PubMed 12269648]

8. Ciprandi G, Canonica WG, Grosclaude M et al. Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy. 2002; 57:586-91. [PubMed 12100298]

9. Bende M, Carrillo T, Vona I et al. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2002; 88:617-23. [IDIS 482210] [PubMed 12086370]

10. AstraZeneca, Wilmington, DE: Personal communication.

11. Mygind N, Clark TJH. Topical steroid treatment for asthma and rhinitis. London: Bailliere Tindall; 1980:89,91,152,159,172.

12. Andersson M, Svensson C, Persson C et al. Dose-dependent effects of budesonide agueous nasal spray on symptoms in a daily nasal allergen challenge model. Ann Allergy Asthma Immunol. 2000; 85:279-83. [IDIS 454624] [PubMed 11061470]

13. Day J, Carrillo T. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 1998; 102(6 Part 1):902-8. [IDIS 424214] [PubMed 9847429]

14. Creticos P, Fireman P, Settipane G et al, for the Rhinocort Aqua Study Group. Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Allergy Asthma Proc. 1998;19:285-94.

15. Meltzer EO. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 1998; 81:128-34. [IDIS 412928] [PubMed 9723557]

16. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs. 1992;44:375-407.

17. AstraZeneca. How to use Rhinocort Aqua. Wilmington, DE; April 2002. From AstraZeneca website (). Accessed 2003 March 4.

18. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002; 89:479-84. [IDIS 490491] [PubMed 12452206]

19. Galant SP, Wilkinson R. Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options? BioDrugs. 2001; 15:453-63.

20. Pedersen S. Assessing the effect of intranasal steroids on growth. J Allergy Clin Immunol. 2001; 108(1 Suppl):S40-4. [IDIS 467845] [PubMed 11449205]

a. AstraZeneca. Rhinocort Aqua (budesonide nasal spray) prescribing information. Wilmington, DE; 2004 Aug.

More Rhinocort Aqua eent resources

• Rhinocort Aqua eent Side Effects (in more detail)
• Rhinocort Aqua eent Use in Pregnancy & Breastfeeding
• Rhinocort Aqua eent Drug Interactions
• Rhinocort Aqua eent Support Group
• 3 Reviews for Rhinocort Aqua eent - Add your own review/rating

Compare Rhinocort Aqua eent with other medications

• Hay Fever